The Journal of Steroid Biochemistry and Molecular Biology
Издатель: Elsevier · ISSN 0960-0760 · 37 статей
- Jan-Åke Gustafsson (1943–2026): A pioneering scientist who bridged steroid biochemistry, nuclear receptor biology, and integrative physiology
- Multi-omics studies show that naringin improves cyclophosphamide-induced testicular and intestinal damage by enhancing energy metabolism
- Editorial Board
- Luteinizing hormone regulates seasonal steroidogenesis locally in the prostate of the muskrat (Ondatra zibethicus)
- Tissue-predominant estrogen metabolic remodeling in adenomyosis revealed by LC-MS/MS profiling
- Deciphering aldosterone deficiency and pseudodeficiency in infancy by targeted GC-MS urinary steroid metabotyping
- Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS
- Methodological contributors to estrous-cycle variability in DHEA-induced mouse models of polyendocrine metabolic ovarian syndrome
- Endocrine disrupting effects of estrone on male Siniperca chuatsi: From gonadal remodeling to gene regulation
- Postnatal expression of phoenixin-14 and GPR173 gene and protein in the mice testis and its effect on steroidogenesis in the early stage
- FDFT1 is associated with ovarian reserve and regulates proliferation and steroidogenesis in the human granulosa cell line KGN via the AKT/mTOR signaling pathway
- Increased levels of long-chain acylcarnitines and polyunsaturated fatty acids in girls with premature adrenarche: An exploratory longitudinal metabolomics study
- Estriol is a stronger transcriptional activator than is either 17β-estradiol or estrone of human and elephant shark estrogen receptor-alpha and estrogen receptor-beta transfected into COS-7 cells
- Targeting steroid receptors and aldo-keto reductases of 1C subfamily with bile acid derivatives: in vitro and in silico insights
- Androgen profiles in full-term maternal-placental-fetal units
- An advocacy for investigation of a “new” estrogen metabolite as a stable epoxide
- Development of steroidal molecules for targeted breast cancer therapy: Endocrine resistance and innovative drug design
- Exploring the putative role of EGFR in prostate cancer: Interactions with androgen and estrogen receptors
- Pentadecanoic acid as a potential endogenous mTOR modulator for age-related female infertility: Mechanistic insights, molecular docking evidence, and therapeutic perspectives
- Estrogen deficiency-induced lipid dysregulation in menopause: Mechanisms, metabolic consequences, and therapeutic strategies
- The history of the discovery of estetrol
- Flavonoids as promising natural therapeutics in ovarian cancer treatment: A comprehensive review
- Molecular mechanisms of Polyendocrine Metabolic Ovarian Syndrome and identification of novel druggable targets for drug discovery and repositioning
- Aromatase inhibitors as endocrine modulators: From breast cancer therapy to male off-label use and doping practice
- Comparative in silico evaluation of steroidal and non-steroidal sulfamates as potential human steroid sulfatase inhibitors
- Progesterone reduces epithelial proliferation and attenuates prostatic hyperplasia in spontaneously hypertensive rats
- PPAR-γ alleviates preeclampsia-associated placental oxidative stress with involvement of the PI3K/Akt signaling pathway
- Vitamin D deficiency associated dyslipidemia in type 2 diabetes and changes following vitamin D2 supplementation
- Synthesis, molecular dynamics, and functional analysis of mitochondria-targeted estrogens through estrogen receptors
- Evaluation of Murrayanine’s anticancer potential in breast cancer: Integrative computational, in vitro, and nanoparticle delivery approaches